It’s a question everyone is asking. How can we get some of that "stuff" going on in Silicon Valley over in our own neck of the woods? The thriving innovation, the entrepreneurship, the technology, the money.
For starters, I recommend you watch a presentation by a fellow well known around Silicon Valley, but new to me: Steve Blank and his talk, The Secret History of Silicon Valley.
Podcast Sponsor: Ingenuity- iReport: The fastest way to get meaning from your expression data
Listen (3:50) Steve Burill: New Model for Big Pharma
Listen (7:06) Dan Vorhaus: The Myriad Case
Listen (3:36) Russ Altman: Personal Genomics and Patent Law
Listen (3:43) Mike Snyder: Million Dollar Interpretation
Listen (2:50) Howard McLeod: PGENI
Listen (2:08) Jonathan Eisen: Why Open Science?
Listen (3:12) George Church: Scientists and the Public
Listen (4:25) Ron Davis: Fit Between University and Industry
Listen (3:01) Greg Scott-Will China Soon Have a Steve Jobs?
NOTE: It’s important to acknowledge that mendelspod has been made possible through the generous support of our sponsors throughout the year. We thank all of them for their partnership. We wish them and all of you a very happy holiday.
Podcast Sponsor: Ingenuity - The fastest way to obtain biological meaning from your expression data. Get a free iReport
Guest:
Dr. Ron Davis, Director, Stanford Genome Technology Center, Bio and Contact Info
Listen (2:04) Money from prize to research chronic fatique syndrome
Listen (6:48) Bringing engineers to clinical medicine
Listen (8:04) Fit between university lab and commercial development
Listen (5:47) Fan of targeted analysis of genome
Listen (3:17) Should scientists engage general public?
Listen (6:32) What about technology drives you?
Listen (3:29) Is NIH funding academic welfare?
Listen (11:18) Thoughts on 'open science'
Listen (1:33) How do you characterize yourself?
We’re delighted to welcome to mendelspod a veteran of the life science arena, Dr. Ron Davis. He’s the director of the Stanford Genome Technology Center and winner of this year’s Gruber Genetics Prize. The prize was presented to Ron a couple weeks ago at the ASHG ho-down in Montreal. Ron has been a leader in the area of genomics and high throughput biochemical techniques and been involved in the spinoff of multiple start-up companies from his lab at Stanford. He’s a co-founder of ParAllele, a company later purchased by Affymetrix and is former advisor to Ion Torrent, whose semiconductor sequencing technology is dramatically reducing the cost of sequencing.
Ron shares with us some of the current technology that he's working on and talks about how he goes about it. In a very candid interview, Ron talks about issues around NIH funding and the growing 'open science' movement.
© 2023 de novo productions · Privacy · Terms· Underwriting · Contact
